All Stories

Chutes & Ladders—J&J vet jumps to Affinia

Veteran scientist Hideo Makimura, M.D., Ph.D., is going fully preclinical by joining gene therapy biotech Affinia Therapeutics as chief medical officer. Makimura most recently served in leadership roles at J&J.

Feb 9, 2025 - 21:44
 0
Chutes & Ladders—J&J vet jumps to Affinia
Veteran scientist Hideo Makimura, M.D., Ph.D., is going fully preclinical by joining gene therapy biotech Affinia Therapeutics as chief medical officer. Makimura most recently served in leadership roles at J&J.
Read More

Tags:

Previous Article

Acelyrin to be absorbed into Alumis in all-stock merger

Next Article

Eli Lilly's next R&D focus: Testing incretin meds in neuro, immunology fields

Related Posts

Pfizer's investigational candidate combo cuts prostate cancer progression by 49% in phase 1

Pfizer's investigational candidate combo cuts prostate ...

Feb 11, 2025  0

Liver transplant specialist OrganOx raises $142M for tissue support system

Liver transplant specialist OrganOx raises $142M for ti...

Feb 24, 2025  0

Sanofi takes $250M hit after gamble on J&J E. coli vaccine ends in phase 3 failure

Sanofi takes $250M hit after gamble on J&J E. coli vacc...

Feb 13, 2025  0